Evidence map›Paper›PMID 34320062›Full record

ArticleArquivos brasileiros de cardiologia2021

Accuracy of Post-thrombolysis ST-segment Reduction as an Adequate Reperfusion Predictor in the Pharmaco-Invasive Approach.

Henrique Tria Bianco, Rui Povoa, Maria Cristina Izar, Braulio Luna Filho, Flavio Tocci Moreira, Edson Stefanini, Henrique Andrade Fonseca, Adriano Henrique Pereira Barbosa, Claudia Maria Rodrigues Alves, Adriano Mendes Caixeta and 7 more

Abstract read
In one paragraph

Article in Arquivos brasileiros de cardiologia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Coagulation Markers and Myocardial Blush Grade in STEMI: Identifying Potential Predictors of Microvascular Reperfusion.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Henrique Tria BiancoEscola Paulista de Medicina da Universidade Federal de São Paulo, São Paulo, SP - Brasil.ORCID 0000-0001-6746-8327
Rui PovoaUniversidade Federal de Sao Paulo, São Paulo, SP - Brasil.ORCID 0000-0002-4295-9151
Maria Cristina IzarUniversidade Federal de Sao Paulo, São Paulo, SP - Brasil.ORCID 0000-0002-5738-2623
Braulio Luna FilhoUniversidade Federal de Sao Paulo, São Paulo, SP - Brasil.
Flavio Tocci MoreiraEscola Paulista de Medicina da Universidade Federal de São Paulo, São Paulo, SP - Brasil.
Edson StefaniniEscola Paulista de Medicina da Universidade Federal de São Paulo, São Paulo, SP - Brasil.
Henrique Andrade FonsecaEscola Paulista de Medicina da Universidade Federal de São Paulo, São Paulo, SP - Brasil.ORCID 0000-0001-8360-8465
Adriano Henrique Pereira BarbosaEscola Paulista de Medicina da Universidade Federal de São Paulo, São Paulo, SP - Brasil.
Claudia Maria Rodrigues AlvesEscola Paulista de Medicina da Universidade Federal de São Paulo, São Paulo, SP - Brasil.
Adriano Mendes CaixetaEscola Paulista de Medicina da Universidade Federal de São Paulo, São Paulo, SP - Brasil.
Iran GonçalvesUniversidade Federal de Sao Paulo, São Paulo, SP - Brasil.
Pedro Ivo de Marqui MoraesUniversidade Federal de Sao Paulo, São Paulo, SP - Brasil.
Renato Delascio LopesEscola Paulista de Medicina da Universidade Federal de São Paulo, São Paulo, SP - Brasil.
Angelo Amato Vincenzo de PaolaEscola Paulista de Medicina da Universidade Federal de São Paulo, São Paulo, SP - Brasil.
Dirceu AlmeidaUniversidade Federal de Sao Paulo, São Paulo, SP - Brasil.ORCID 0000-0002-2178-1518
Valdir Ambrosio MoisesEscola Paulista de Medicina da Universidade Federal de São Paulo, São Paulo, SP - Brasil.
Francisco A H FonsecaUniversidade Federal de Sao Paulo, São Paulo, SP - Brasil.ORCID 0000-0002-9911-4598

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrimary percutaneous coronary intervention is considered the "gold standard" for coronary reperfusion. However, when not available, the drug-invasive strategy is an alternative method and the electrocardiogram (ECG) has been used to identify reperfusion success.

objectivesOur study aimed to assess ST-Segment changes in post-thrombolysis and their power to predict recanalization and using the angiographic scores TIMI-flow and Myocardial Blush Grade (MBG) as an ideal reperfusion criterion.

methods2,215 patients with ST-Segment Elevation Myocardial Infarction (STEMI) undergoing fibrinolysis [(Tenecteplase)-TNK] and referred to coronary angiography within 24 h post-fibrinolysis or immediately referred to rescue therapy were studied. The ECG was performed pre- and 60 min-post-TNK. The patients were categorized into 2 groups: those with ideal reperfusion (TIMI-3 and MBG-3) and those with inadequate reperfusion (TIMI and MBG <3). The ECG reperfusion criterion was defined by the reduction of the ST-Segment >50%. A p-value <0.05 was considered for the analyses, with bicaudal tests.

resultsThe ECG reperfusion criterion showed a positive predictive value of 56%; negative predictive value of 66%; sensitivity of 79%; and specificity of 40%. There was a weak positive correlation between ST-Segment reduction and ideal reperfusion angiographic data (r = 0.21; p <0.001) and low diagnostic accuracy, with an AUC of 0.60 (95%CI: 0.57-0.62).

conclusionThe ST-Segment reduction was not able to accurately identify patients with adequate angiographic reperfusion. Therefore, even patients with apparently successful reperfusion should be referred to angiography soon, to ensure adequate macro and microvascular coronary flow.

Indexed as

Myocardial InfarctionPercutaneous Coronary InterventionCoronary AngiographyElectrocardiographyFibrinolysisHumansMyocardial ReperfusionThrombolytic TherapyTreatment Outcome

Identifiers

PMID34320062
PMCPMC8294746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.